检索历史清除

首页> Pediatric Pulmonology> SAFETY, TOLERABILITY, AND PHARMACODYNAMICS OF COMBINATION LUMACAFTOR/IVACAFTOR THERAPY IN PATIENTS AGED 6-11 YRS WITH CF HOMOZYGOUS FOR THE F508DEL-CFTR MUTATION

SAFETY, TOLERABILITY, AND PHARMACODYNAMICS OF COMBINATION LUMACAFTOR/IVACAFTOR THERAPY IN PATIENTS AGED 6-11 YRS WITH CF HOMOZYGOUS FOR THE F508DEL-CFTR MUTATION

导出原文传递

翻译打印收藏纠错

作者： Milla, C. ^[1] ; Ratjen, F. ^[2] ; Marigowda, G. ^[3] ; Liu, F. ^[4] ; Waltz, D. ; Rosenfeld, M.

作者单位： Seattle Childrens Hosp, Seattle, WA USA ^[1] Hosp Sick Children, Toronto, ON, Canada ^[2] Vertex Pharmaceut Inc, Boston, MA USA ^[3] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA ^[4]

发布时间 2020-08-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交